test

Harold Schaaff

@Soleus Capital Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$1.291BTotal holdings87
Assets growth rate13.9%Assets growth rate (2-Q avg)-0.97%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Soleus Capital Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 87 positions.

Assets under management

The assets under management (AUM) of Soleus Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.291B in assets, with a quarterly growth rate of 13.9% and a 2-quarter average growth rate of -0.97%. The portfolio is managed by Harold Schaaff, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SNDXSyndax Pharmaceuticals Inc
Recent Activity
Increased 32.01%
1.63%
$21.001M
1.091M shares@ $19.25 avg price
MRUSMerus N V
Recent Activity
Increased 5.85%
1.55%
$19.9M
398,321 shares@ $49.96 avg price
EDAPEdap Tms S A
Recent Activity
Increased 0.22%
1.45%
$18.639M
7.309M shares@ $2.56 avg price
CELCCelcuity Inc
Recent Activity
Increased 2.83%
1.44%
$18.569M
1.245M shares@ $14.91 avg price
KROSKeros Therapeutics Inc
Recent Activity
Increased 1.36%
1.01%
$13.043M
224,600 shares@ $58.07 avg price
BHCBausch Health Cos Inc
Recent Activity
Increased 18.08%
0.9%
$11.62M
1.424M shares@ $8.16 avg price
PHVSPharvaris N V
Recent Activity
Increased 49.76%
0.86%
$11.078M
598,169 shares@ $18.53 avg price
OFIXOrthofix Med Inc
Recent Activity
Increased 1090.07%
0.74%
$9.48M
606,933 shares@ $15.62 avg price
VSTMVerastem Inc
Recent Activity
Increased 70.23%
0.66%
$8.456M
2.828M shares@ $2.99 avg price
KNSAKiniksa Pharmaceuticals Intl
Recent Activity
Increased 51.25%
0.59%
$7.559M
302,500 shares@ $24.99 avg price